-
Economic Burden of Chronic Kidney Disease (CKD) in Type 2 Diabetes (T2D), Considering the Costs of Cardiovascular Hospitalization Events in Colombia
Mar 10, 2025, 14:00 PM -
Demographic Characteristics, Utilization Trends, and Access to GLP-1 Agonists Among Adults in a Nationally Representative Pharmacy Database
Mar 10, 2025, 14:00 PM -
The Use of Social Media Listening to Collect Oncology-Specific Patient Experience Data: A Scoping Review
Mar 10, 2025, 14:00 PM -
Economic Evaluations of Imaging Guidance for Percutaneous Coronary Interventions: A Scoping Review
Mar 10, 2025, 14:00 PM -
Acute Care visits and Readmissions Among Commercial Plan Enrollees with Heart Failure with Preserved Ejection Fraction (HFpEF) by Obesity Classes
Mar 10, 2025, 14:00 PM -
Evaluating the Cost-Effectiveness of Polygenic Risk Score-Guided Breast Cancer Screening Using a Discrete Event Simulation Model
Mar 10, 2025, 14:00 PM -
The Utilization of Qualitative Evidence Synthesis in Brazil’s Public Health System: A Qualitative Analysis
Mar 10, 2025, 14:00 PM -
Automating Health Economic Model Quality Check With a Model Generator
Mar 10, 2025, 14:00 PM -
Patient and Diagnostic Delay in Patients With Breast or Colorectal Cancer
Mar 10, 2025, 14:00 PM -
Evaluating the Influence of User-Complexity on Individual Preferences for Upper Limb Prosthetic Selection: Measurement Tool Development for a Discrete Choice Experiment
Mar 10, 2025, 14:00 PM -
Taletrectinib vs Entrectinib in ROS1-Positive (ROS1+) Non-Small Cell Lung Cancer (NSCLC): A Matching-Adjusted Indirect Comparison (MAIC)
Mar 10, 2025, 14:00 PM -
Characteristics of Adults With Type 2 Diabetes Who Are Not Treated With A Glucose-Lowering Agent: A Retrospective Cohort Study
Mar 10, 2025, 14:00 PM -
JAV-RARAS: Analysis of the Value-Driven Care Journey for Patients With Rare Diseases in Brazil Applying the Time-Driven Activity-Based Costing Methodology
Mar 10, 2025, 14:00 PM -
Approaches to Model Patient And Carer Utilities and Disutilities of Adverse Events in Economic Models for Rare Disease Treatments in NICE Appraisals
Mar 10, 2025, 14:00 PM -
Cost Savings With Treosulfan and Fludarabine (Treo/Flu) vs. Busulfan and Fludarabine (Bu2/Flu) Conditioning Regimen in Patients Undergoing Allogeneic HSCT for Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Mar 10, 2025, 14:00 PM -
Treatment Patterns in the Management of Alopecia Areata in a Colombian HMO During 2015-2023: A Real-World Data Study
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of a Potential Policy to Ban Alcohol Advertising in Australia: A Modeling Study
Mar 10, 2025, 14:00 PM -
Analysis of Patient-Reported Outcomes of MCO-010 Mutation Agnostic Optogenetic Therapy for Retinitis Pigmentosa: 12-Month Results from a Phase 2b Randomized, Sham-Controlled, Patient- and Assessor-Masked Clinical Trial (RESTORE)
Mar 10, 2025, 14:00 PM -
Analysis of Reimbursement Outcomes for Oncology Therapies in Quebec, Canada
Mar 10, 2025, 14:00 PM -
Effects of Pre-existing Mental Health Disorders on Endocrine Therapy Adherence in Patients with Breast Cancer
Mar 10, 2025, 14:00 PM
